GINA 2019: a fundamental change in asthma management
GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.http://bit.ly/310LLzE
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes
Funder: Global Initiative for Asthma